Malaria Vaccine Effective in Latest Trials

Malaria Vaccine Effective in Latest Trials
Title: Malaria Vaccine Effective in Latest Trials
Category: Health News
Created: 12/9/2008 2:00:00 AM
Last Editorial Review: 12/9/2008

Rib-X Pharmaceuticals Reports Positive Top-Line Results From Phase 2 Study Of Delafloxacin
Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, announced positive topline results from a Phase 2 clinical trial with the intravenous form of its novel anionic quinolone antibiotic, delafloxacin (RX-3341).

A Signaling Protease Required For Melanization In Drosophila Affects Resistance And Tolerance Of Infections
Organisms evolve two routes to surviving infections-they can resist pathogen growth (resistance) and they can endure the pathogenesis of infection (tolerance). The sum of these two properties together defines the defensive capabilities of the host. Typically, studies of animal defenses focus on either understanding resistance or, to a lesser extent, tolerance mechanisms, thus providing little understanding of the relationship between these two mechanisms.

Discovery Of Microbe In Roundworm Provides Animal Model For 'Emerging Pathogen'
Microsporidia are single-celled parasites that are capable of causing infections in humans - primarily people with compromised immune systems, such as those infected with HIV or who have undergone organ transplants. An article in this week's issue of PLoS Biology documents a newly discovered species of microsporidia, which infects C. elegans, the round worm used as a model system by developmental biologists.

Novavax Announces Preclinical Data For Respiratory Syncytial Virus Vaccine Candidate
Novavax, Inc. (Nasdaq: NVAX) announced that Dr. Trudy Morrison, PhD, Professor of Molecular Genetics and Microbiology, University of Massachusetts Medical School, will be presenting the results of a preclinical study of a vaccine candidate for the prevention of respiratory syncytial virus ("RSV") at the 2nd Vaccine Congress in Boston, MA on December 9, 2008. This study was funded by Novavax, Inc.

New Mexico, Texas, Colorado Alerts Bus Passengers To TB Case That Traveled In August
The New Mexico, Colorado, and Texas Departments of Health announced today that a person recently diagnosed with infectious tuberculosis (TB) in New Mexico traveled on an interstate commercial bus that originated from El Paso, Texas. The bus traveled through New Mexico to its final destination of Greeley, Colorado.

Are Americans Just Too Chronically Ill?

Are Americans simply too healthy to be sick than any other people in other countries in the world, or they simply have more access to a better health care system? If they are just too healthy, then why are there so many health insurance companies in the US, perhaps some of the largest health insurance companies than any other health insurance companies in the world? Or if the American people are just as sick as other people in the world, then do they just have access to a better healthcare system? What class of American people is sicker then the other; men or women, young or old?

Podcasts: HIV Transmission Rates in the United States

Podcasts: HIV Transmission Rates in the United States
This podcast describes in detail HIV transmission rates in the United States and the success of prevention efforts nationwide.

HIV Transmission Rates in the United States
This fact sheet examines a journal article from JAIDS which shows that HIV transmission has declined significantly since the early days of the epidemic and indicates success in HIV prevention efforts.